GlucoTrack【GCTK】銘柄情報

GlucoTrack Inc (GCTK) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.40

( 2.96% )

買値

0.2772

売値

0.5016

出来高

425,332

平均取引量 (3 か月)

US$ 4,447,112

財務取引量

US$ 169,256

0.36685 日の範囲 0.4191

0.2907 52 週間の範囲 14.14

時価総額

2.504M

企業価値

1.662M

前日終値

0.3885

始値

0.37

時刻

600

0.4

(formt)

最終取引時間

VWAP

0.397938

歳入

純利益

-16.89M

発行済株式数

6,259,279

浮動株比率 (%)

99.07%

機関投資家保有比率 (%)

4.19%

配当利回り

PER

-0.02

株価売上高倍率 (PSR)

1 株当たり利益 (EPS)

-17.09

ベータ

0.76

GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and i... GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey. 詳細を表示

セクター

Health Care

業界

Health Care Equipment & Supplies

ウェブサイト

glucotrack.com

本社

Rutherford, United States

設立

2026

GlucoTrack Inc is listed in the Health Care sector of the ナスダック市場 with ticker GCTK. The last closing price for GlucoTrack was US$0.39. Over the last year, GlucoTrack shares have traded in a share price range of US$ 0.2907 to US$ 14.14.

GlucoTrack currently has 6,259,279 shares in issue. The market capitalisation of GlucoTrack is US$2.50 million. GlucoTrack has a price to earnings ratio (PE ratio) of -0.02.

Glucotrack Announces USPTO Notice of Allowance for Patent Application Covering Its Implantable CBGM Platform

RUTHERFORD, N.J., July 08, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (“Glucotrack”, or the “Company”...

Form PRE 14A - Other preliminary proxy statements

Glucotrack to Highlight Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association’s 2026 Scientific Sessions

RUTHERFORD, N.J., May 26, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the...

Glucotrack Announces IDE Submission for U.S. Clinical Study of its Novel Implantable Continuous Blood Glucose Monitoring Technology

RUTHERFORD, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.078	24.2236024845	0.322	0.44	0.301	3581460	0.36211956	CS
4	0.0197	5.18012095714	0.3803	0.449	0.301	1073149	0.36674192	CS
12	-0.3101	-43.6699056471	0.7101	1.28	0.2907	4530676	0.81049707	CS
26	-3.4	-89.4736842105	3.8	4.24	0.2907	2806655	0.92565796	CS
52	-5.4	-93.1034482759	5.8	14.14	0.2907	1817927	2.94986332	CS
156	0.031	8.40108401084	0.369	15.9	0.0531	5034392	0.55264187	CS
260	-2.76	-87.3417721519	3.16	15.9	0.0531	3661013	0.62731792	CS